Jamal Mahajna
Qiryat Shemona, Z, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Allosteric kinase inhibition in hematological malignancies: from asciminib to emerging regulatory sites.
Journal: Biochemical pharmacology
Published: July 10, 2026
Passenger variants as pan-clonal markers of pediatric AML: Implications for molecular MRD.
Journal: HemaSphere
Published: December 30, 2025
Hypoxic conditions confer chemoresistance to crizotinib but not to imatinib in chronic myeloid leukemia cells.
Journal: Hematology, transfusion and cell therapy
Published: February 23, 2025
Chaga Mushroom Triterpenoids Inhibit Dihydrofolate Reductase and Act Synergistically with Conventional Therapies in Breast Cancer.
Journal: Biomolecules
Published: August 28, 2024
Overcoming Chemoresistance in Cancer: The Promise of Crizotinib.
Journal: Cancers
Published: June 11, 2024
Plant-Derived Epi-Nutraceuticals as Potential Broad-Spectrum Anti-Viral Agents.
Journal: Nutrients
Published: October 17, 2023
Ovarian cancer ascites confers platinum chemoresistance to ovarian cancer cells.
Journal: Translational oncology
Published: September 21, 2023
Secreted Soluble Factors from Tumor-Activated Mesenchymal Stromal Cells Confer Platinum Chemoresistance to Ovarian Cancer Cells.
Journal: International journal of molecular sciences
Published: February 24, 2023
TRAF3 suppression encourages B cell recruitment and prolongs survival of microbiome-intact mice with ovarian cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 07, 2023
2-Hydroxyestradiol Overcomes Mesenchymal Stem Cells-Mediated Platinum Chemoresistance in Ovarian Cancer Cells in an ERK-Independent Fashion.
Journal: Molecules (Basel, Switzerland)
Published: January 03, 2022
Natural Products Targeting Cancer Stem Cells for Augmenting Cancer Therapeutics.
Journal: International journal of molecular sciences
Published: October 05, 2021
Last Updated: 09/26/2026